CDC Mpox Partner Updates
CDC | June 28, 2023
 

CDC continues to monitor mpox case reports and related surveillance data as case incidence continues to decrease. However, a new cluster of mpox cases reported in early May showed the virus is still spreading, and we need to remain alert. On June 23, CDC released an MMWR, Notes from the Field: Emergence of an Mpox Cluster Primarily Affecting Persons Previously Vaccinated Against Mpox – Chicago, Illinois, March 18-June 12, 2023. During this period, 40 laboratory-confirmed mpox cases were identified in Chicago, including 22 patients who were fully vaccinated against mpox. Although the cause of this cluster has not yet been determined, health departments are encouraged to report vaccination status of mpox patients to CDC for rapid detection of similar clusters among persons who were previously vaccinated.

 

Mpox isn’t over. As summer events continue, communication to clinicians and the public about mpox prevention and detection is critical. A new way to share reliable and accurate mpox information is by embedding CDC’s mpox content into your website. The CDC mpox microsite is a collection of syndicated content that can seamlessly become part of your website's content. The mpox microsite includes the most popular or frequently visited pages. You can find more information about microsites and how you use them in the attached information sheet.

 

In addition, consider using CDC’s latest social media graphics and messages to share information about mpox with your audiences. The messages highlight how important it is to get both doses of the vaccine for maximum protection. Social media messages and images can be found in the attached documents.

 

Thank you for your partnership.

 

Recent Updates and Publications

 

  • A new FAQ series from KFF’s Greater Than Mpox and CDC, including new videos featuring Dr. Demetre Daskalakis that answer questions about who should get vaccinated, common symptoms, testing and treatment options, and more. Watch and share!

  • SAMHSA released a new Notice of Funding Opportunity: Minority HIV/AIDS Fund: Integrated Behavioral Health and HIV Care for Unsheltered Populations Pilot Project, which serves people experiencing unsheltered homelessness. Given the population of focus for this NOFO, it includes the following required activity:

    • Use award resources, including funds or staff, for mpox activities conducted in conjunction with SAMHSA supported work as allowable in SAMHSA’s Mpox Dear Colleagues letter. Such activities include, but are not limited to, navigating people served by award funds to testing, treatment, and prevention resources identified through collaboration with local health departments and mental health support of individuals with mpox served by this award or referral/navigation to these services. 

    • Please circulate throughout your networks as appropriate. Note the deadline for this NOFO is July 24, 2023, so there is limited time to apply.

  • CDC encourages participation in STOMP Trial for Tecovirimat (TPOXX)

    • Evidence-based interventions are needed to respond to current and future mpox outbreaks within and beyond the United States. To help meet domestic and international mpox response goals, CDC is urging clinicians to let patients with mpox know that oral tecovirimat is available through STOMP and encourage them to enroll. Providers should inform patients about STOMP so they can consider enrolling in the study. However, enrollment in the study is voluntary, and patients who decline to take part, or who do not meet the criteria to participate, can still obtain tecovirimat if recommended. For more information about obtaining TPOXX or about the STOMP study, visit www.cdc.gov/poxvirus/mpox/clinicians/obtaining-tecovirimat.html or  https://www.stomptpoxx.org/main.

    • Related: Updated Information for Healthcare Providers: Tecovirimat (TPOXX) and Guidance for Tecovirimat Use pages are now live.

  • CDC Foundation released a Request for Proposals for Preventing Mpox Resurgence by Increasing Vaccine Confidence & Community Immunity Through CBO Partnerships. 

    • The CDC Foundation seeks to support up to 50 community-based organizations (CBOs) in their efforts to increase mpox vaccine coverage and subsequent community immunity. Funding ($25,000 - $100,000) will be provided to implement a wide range of innovative, culturally appropriate, and situationally sensitive mpox vaccination confidence and prevention education strategies to prevent a resurgence.

    • The CDC Foundation will host a prospective applicant webinar to answer questions related to this RFP on Friday, June 23, 2023, at 2pm ET. Advanced registration is required for the webinar: https://cdcfoundation.zoom.us/meeting/register/tJIlce6urzouHtxv2nZYiXtp0B38VnuC26zs. After registering, you will receive a confirmation email containing information for joining the webinar.

    • Response Due Date: Friday, July 14, 2023, at 5:00 PM ET. Contact: mpoxvaccine@cdcfoundation.org

 

Feel free to share this email with your organization’s members. If you have questions or would like additional information, please email CDC’s Mpox Policy/Partnerships Task Force at eocevent434@cdc.gov.

 

References to non-CDC sites are provided as a service and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed were current as of the date of publication.

  Back to M-pox Index